Role of circRNAs in regulating cell death in cancer: a comprehensive review

Mohamed J Saadh1, Hadi Mohammed Ehymayed2, Tuqa S Alazzawi3

  • 1Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan.

PubMed

Insights

Circular RNAs (circRNAs) show promise as cancer biomarkers and therapeutic targets. This review explores how circRNAs influence cancer cell death processes like apoptosis, aiding in developing new treatments.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Cancer remains a significant global health challenge despite advances in surgery, radiation, and chemotherapy.
  • Circular RNAs (circRNAs) are stable RNA molecules involved in gene regulation, including microRNA (miRNA) binding.
  • Emerging research highlights the significant role of circRNAs in various cancer types.

Purpose of the Study:

  • To review and understand the impact of circRNAs on cancer cell death pathways.
  • To investigate the potential of circRNAs as therapeutic targets for cancer treatment.
  • To explore the relationship between circRNAs and apoptosis, autophagy, and ferroptosis in cancer.

Main Methods:

  • Literature review and synthesis of existing research on circRNAs and cancer.
  • Analysis of studies investigating circRNA involvement in apoptosis, autophagy, and ferroptosis.
  • Evaluation of circRNAs as potential biomarkers and therapeutic targets in oncology.

Main Results:

  • CircRNAs play a substantial role in the development and progression of various cancers.
  • Dysregulation of circRNAs is linked to altered cancer cell death mechanisms.
  • circRNAs have the potential to be targeted for cancer therapy to induce tumor cell death.

Conclusions:

  • Understanding circRNA functions in cancer cell death is crucial for novel therapeutic strategies.
  • Targeting circRNAs may offer a promising approach to enhance chemotherapy efficacy and combat cancer.
  • Further research is needed to fully elucidate the therapeutic potential of circRNAs in cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K